Skip to main content

Carbetapentane / Guaifenesin Dosage

Medically reviewed by Drugs.com. Last updated on Aug 3, 2023.

Applies to the following strengths: 8 mg-200 mg; 7.5 mg-150 mg/5 mL; 60 mg-600 mg; 20 mg-75 mg/5 mL; 7.5 mg-200 mg/5 mL; 5 mg-1000 mg; 60 mg-1000 mg; 20 mg-100 mg/5 mL; 10 mg-100 mg/5 mL; 60 mg-1200 mg; 60 mg-900 mg

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Cough

Carbetapentane-guaifenesin 10 mg-100 mg/5 mL oral liquid:
5 to 10 mL orally every 4 to 6 hours not to exceed 6 doses daily.

Carbetapentane-guaifenesin 5 mg-1000 mg oral tablet, extended release, Carbetapentane-guaifenesin 60 mg-1000 mg oral tablet, extended release and Carbetapentane-guaifenesin 60 mg-1200 mg oral tablet, extended release: 1 tablet orally every 12 hours not to exceed 2 tablets daily.

Carbetapentane-guaifenesin 7.5 mg-150 mg/5 mL oral syrup:
10 mL orally every 4 to 6 hours not to exceed 6 doses daily.

Carbetapentane-guaifenesin 7.5 mg-200 mg/5 mL oral suspension, extended release:
10 mL orally every 12 hours.

Carbetapentane-guaifenesin 8 mg-200 mg oral capsule:
2 capsules orally every 4 to 6 hours.

Carbetapentane-guaifenesin 20 mg-100 mg/5 mL oral syrup:
10 mL orally every 4 to 6 hours.

Carbetapentane-guaifenesin 20 mg-75 mg/5 mL oral liquid:
5 to 10 mL orally every 4 to 6 hours.

Carbetapentane-guaifenesin 30 mg-400 mg oral capsule, extended release:
1 to 2 capsules orally every 12 hours not to exceed 4 tablets daily.

Carbetapentane-guaifenesin 60 mg-600 mg oral tablet, extended release:
1 to 2 tablets orally every 12 hours not to exceed 4 tablets daily.

Usual Pediatric Dose for Cough

Carbetapentane-guaifenesin 10 mg-100 mg/5 mL oral liquid:
6 to 11 years: 5 mL orally every 4 to 6 hours not to exceed 6 doses daily.
12 years or older: 5 to 10 mL orally every 4 to 6 hours not to exceed 6 doses daily.

Carbetapentane-guaifenesin 5 mg-1000 mg oral tablet, extended release, and Carbetapentane-guaifenesin 60 mg-1000 mg oral tablet, extended release:
6 to 11 years: 0.5 tablet orally every 12 hours not to exceed 1 tablet daily.
12 years or older: 1 tablet orally every 12 hours not to exceed 2 tablets daily.

Carbetapentane-guaifenesin 7.5 mg-150 mg/5 mL oral syrup:
6 to 11 years: 5 mL orally every 4 to 6 hours not to exceed 6 doses daily.
12 years or older: 10 mL orally every 4 to 6 hours not to exceed 6 doses daily.

Carbetapentane-guaifenesin 7.5 mg-200 mg/5 mL oral suspension, extended release:
2 to 4 years: 2.5 mL orally every 12 hours.
5 to 11 years: 5 mL orally every 12 hours.
12 years or older: 10 mL orally every 12 hours.

Carbetapentane-guaifenesin 8 mg-200 mg oral capsule:
6 to 11 years: 1 capsule orally every 4 to 6 hours.
12 years or older: 2 capsules orally every 4 to 6 hours.

Carbetapentane-guaifenesin 20 mg-100 mg/5 mL oral syrup:
2 to 5 years: 2.5 mL orally every 4 to 6 hours.
6 to 11 years: 5 mL orally every 4 to 6 hours.
12 years or older: 10 mL orally every 4 to 6 hours.

Carbetapentane-guaifenesin 20 mg-75 mg/5 mL oral liquid:
2 to 5 years: 2.5 mL orally every 4 to 6 hours.
6 to 11 years: 5 mL orally every 4 to 6 hours.
12 years or older: 5 to 10 mL orally every 4 to 6 hours.

Carbetapentane-guaifenesin 30 mg-400 mg oral capsule, extended release:
6 to 11 years: 1 capsule orally every 24 hours not to exceed 1 capsule daily.
12 years or older: 1 to 2 capsules orally every 12 hours not to exceed 4 capsules daily.

Carbetapentane-guaifenesin 60 mg-1200 mg oral tablet, extended release:
12 years or older: 1 tablet orally every 12 hours not to exceed 2 tablets daily.

Carbetapentane-guaifenesin 60 mg-600 mg oral tablet, extended release:
6 to 11 years: 0.5 to 1 tablet orally every 12 hours not to exceed 2 tablets daily.
12 years or older: 1 to 2 tablets orally every 12 hours not to exceed 4 tablets daily.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dialysis

Data not available

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.